Both options are autologous adipose-based therapies, but they are processed differently and may suit different treatment goals.
- Particle size: nFat is more finely processed than mFat, enabling broader micro-distribution.
- Potency profile: nFat is often chosen for higher-intensity biological signalling.
- Duration: nFat generally has a shorter persistence, while mFat may provide longer biological presence.
- Selection: choice depends on pathology, tissue targets, and your treatment timeline.
At consultation, we assess imaging, symptoms, and prior treatment response to select the most appropriate fat-based regenerative strategy.